In an ongoing East Africa Trade Expo in Nyanza Province – Tanzania, Gulu University officials are exhibiting Covilyce-1, an indigenous herbal medicine used in the treatment of COVID-19.
Covilyce-1 herbal medicine was created by scientists headed by Dr Alice Lamwaka at the Faculty of Biotechnology and Pharmaceutical Studies (Pharm-Biotech), backed by over 200 herbalists from the Acholi sub-region to treat COVID-19. The drug developers were also supported with a million dollar aid from the central government to facilitate it’s mass production and further development.
According to Dr Alice and team, the drug can cure COVID-19 patients within 72 hours of administering. The 10-member team left the country aboard a University bus in a 15-hour journey to attend the December 2-12 event.
Dr Alice informed URN (News Agency) that they decided to take their products to the Expo because it’s an opportunity for them to showcase their discovery and expand their market. She said that Covilyce – 1 formula which is in different packages sold at 30,000 and 50,000 Shillings has been tested and approved by National Drug Authority to cure Covid-19.
Apart from the Covilyce, the team is also exhibiting other herbal remedies made out of indigenous herbs to treat sickle cell, sexually transmitted infections, and diabetes in patients.
Gulu University Assistant Public Relations Officer James Onono Ojok said that the Expo is intended to promote Quality and Innovation to enhance East Africa Community Micro, Small, Medium Scale Enterprises competitiveness and post Covid-19 recovery.
The East Africa Expo brings together East Africa’s six partner states that including Rwanda, Burundi, Kenya, Uganda, South Sudan and host Tanzania for purposes of opening up new market frontiers for their products while bridging the knowledge and technological gaps between them, and promoting the regional integration process.
